PROVIDER PROFILE · NPI 1689761686

Paul GittelmanM.D.

OtolaryngologyPurchase, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,626

Unique beneficiaries

—

Total services

2,353

Distinct HCPCS

Medicare payment

$220K

Peer benchmark

Total Medicare services vs. 677 Otolaryngology providers in NY — top quintile (cohort median 888).

PRESCRIBING · PART D · 2024

Total Rx claims

570

Beneficiaries

—

Total drug cost

$15K

Distinct drugs

Brand share

1.9%

Top prescribed drugs

Prednisone119 claims

Ipratropium Bromide109 claims

Mometasone Furoate77 claims

Pantoprazole Sodium59 claims

Fluticasone Propionate42 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

89.9

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$828

Payment records

By payment type

Food and Beverage$828

Top paying entities

Food and Beverage$828

REFERRAL NETWORK

Where Paul Gittelman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
WHITE PLAINS HOSPITAL MEDICAL CENTER	63	135
RIEMMA, ANGELA	38	53
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	21	41
WINIFRED MASTERSON BURKE REHABILITATION HOSPITAL	17	18
Daniel Colangelo Internal Medicine · Harrison, NY	13	50

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history